NSCMID 2026
SPEAKERS
27 - 30 August 2026, Copenhagen
Malin Hagstrand Aldman
Is a specialist in infectious diseases and senior consultant at Skåne University Hospital, Lund, Sweden.
Her research focuses on Staphylococcus aureus infections and antibiotic treatment, including as Principal Investigator of the COMeBAC trial comparing cloxacillin and benzylpenicillin for PSSA bacteraemia. Clinically, she manages MRSA patients and supports infectious disease care through the Hospital at Home service.
Zoïe Alexiou
Is a Dutch epidemiologist and postdoctoral researcher at Maastricht University specialising in sexually transmitted infections. Drawing on implementation science, her research evaluates how new STI guidelines and diagnostic innovations translate into real-world practice, examining the process and impact from multiple stakeholder perspectives.
Anne Line Engsbro
Is a specialist in Clinical microbiology, Senior consultant at Department of Clinical Microbiology, Zealand University Hospital, Denmark and Clinical associate professor, Department of Clinical Medicine, University of Copenhagen, Denmark.
Her research interests include carbapenemase-producing organisms, infection prevention and control, acute gastroenteritis and postinfectious functional abdominal disorders.
Lars Engstrand
MD, PhD, is Professor of Clinical Microbiology and Director of the Centre for Translational Microbiome Research (CTMR) at Karolinska Institutet, Stockholm. With over 35 years of experience, his research combines microbiology, genomics, and epidemiology to explore the role of the human microbiome in health and disease, with a focus on microbiome-based diagnostics and treatments.
Tristan Ferry
Is an infectiologist at Lyon University Hospital and Head of CRIOAc Lyon, a referral centre for complex bone and joint infections. He leads a multidisciplinary team focused on implant-associated infections and innovative treatments. Through the PHAGEinLYON Clinic programme, he has pioneered phage therapy in France, treating more than 100 patients with complex biofilm-associated infections. His work focuses on advancing phage therapy for difficult-to-treat infections.
Finn Filén
Is a specialist physician in infectious diseases and dermatovenereology, based at the sexual health and HIV clinic Venhälsan at Södersjukhuset in Stockholm, with a clinical and research focus on STIs and PrEP in MSM.
Christian Philip Fischer
MD, PhD, DTMH is a Specialist in Infectious Diseases and Senior Consultant at Department of Infectious Diseases, Hvidovre University Hospital, Denmark, and Clinical Associate Professor at Department of Clinical Medicine, University of Copenhagen, Denmark.
His interests include primary and secondary immunodeficiencies in adults, immunology and severe infections.
Erik Forsblom
Md.PhD. Adjunct professor. Specialist in internal medicine and infectious diseases. Research fields: Staphylococcus aureus bacteremia and bacteremic infections, Covid-19 and immunodeficiencies. Division of Infectious Diseases, Inflammation Center, Helsinki University Hospital, Helsinki, Finland.
Emil Fosbøl
MD, PhD, is Professor of Cardiology and Head of the Unit for Valvular Heart Disease and Endocarditis at Rigshospitalet, Copenhagen. His research focuses on infective endocarditis and valvular heart disease, with more than 100 peer-reviewed publications.
He contributed to the current European endocarditis guidelines and the updated ISCVID-Duke diagnostic criteria, and chairs the landmark ASTERIx trial and the national NIDUS endocarditis registry.
Anna Margrét Halldórsdóttir
MD, PhD, MSc is a Senior Medical Officer at the Centre for Health Security and Communicable Disease Control at the Directorate of Health in Iceland. She has contributed to national efforts in infection prevention, communicable disease control, and antimicrobial resistance strategies, including as a member of the cross-sectoral working group for Iceland’s National Action Plan (NAP) on antimicrobial resistance (AMR). She also serves as Iceland’s national liaison for the JAMRAI-2 project.
Malene Plejdrup Hansen
Is Professor and lead of the “Infections and Antibiotic Use” research group at Aalborg University’s Center for General Practice, Denmark. Her research focuses on optimising the management of community-acquired infections in primary care and improving evidence-based antibiotic use. Since 2019, she has chaired the General Practice Research on Infections Network (GRIN) and led the update of Danish guidelines for acute respiratory tract infections in general practice.
Zitta Barrella Harboe
MD, is Clinical Professor of Infectious Diseases and consultant at Copenhagen University Hospital, Nordsjælland, and Statens Serum Institut. Her research focuses on vaccinology, immunology, and vaccine-preventable diseases in at-risk adults, particularly pneumococcal disease and vaccination of immunocompromised and elderly populations. She has extensive clinical and research experience in infectious diseases, including work with humanitarian organisations.
Terho Heikkinen
MD, PhD, is a specialist in pediatric infectious diseases and Professor of Pediatrics at the University of Turku in Finland.
His major research interest lies in respiratory infections, especially those caused by influenza or respiratory syncytial viruses. He has been active in international research collaboration and served as the chair or board member of many international societies in the field of infectious diseases.
Jannik Helweg-Larsen
Currently works at the Department of Infectious Diseases, Rigshospitalet. Jannik does research in Infectious Diseases and Hematology. Primary interest fields are invasive fungal diseases, endocarditis, HIV-related lymphoma, pneumocystis pneumonia, other opportunistic infections and immunodeficiencies.
Christian Lodberg Hvas
Clinical Professor of Gastroenterology and Head of the Centre for Faecal Microbiota Transplantation (CEFTA) at Aarhus University Hospital, Denmark. His expertise includes intestinal failure, clinical nutrition, and microbiota therapies, particularly faecal microbiota transplantation (FMT). He is a founding member of EurFMT, coordinator of the Harmonize FMT project, and has played a leading role in developing FMT services and training across Denmark and the Faroe Islands.
Søren Jensen-Fangel
MD, DMSc, is Associate Professor at the Department of Infectious Diseases, Aarhus University Hospital, Denmark.
His research and clinical work focus on infections in immunocompromised patients, including those with haematological malignancies and solid organ transplants. In 2022, he co-founded the hospital-level “Infections in the Immunocompromised Host” service at Aarhus University Hospital.
Achim Kaasch
Is Professor of Medical Microbiology and Director of the Institute of Medical Microbiology and Hospital Hygiene at Otto von Guericke University Magdeburg, Germany.
His research focuses on Staphylococcus aureus bloodstream infections and infectious disease diagnostics. He is internationally recognized as the principal investigator of the landmark SABATO trial on early oral switch therapy for S. aureus bloodstream infections.
Maja Skov Kragsnæs
Is an associate professor researching the interplay between the human microbiota and autoimmune and chronic inflammatory diseases. Her work focuses on microbial alterations, intestinal barrier function, and their potential as treatment targets and biomarkers. She combines clinical trials, observational studies, laboratory analyses, and systematic reviews to translate microbiome research into clinical practice.
Oskar Ljunquist
Is an infectious diseases consultant at Helsingborg Hospital and an Associate Professor at Lund University, Sweden. His main research interests include bloodstream infections, antimicrobial resistance (AMR), and vascular graft infections.
Mette Bondo Mønster
MD, PhD student. Central venous catheter-related infections remain a major challenge in patients requiring long-term vascular access. While removal is often recommended, it carries risks and complications. In Saving the Central Venous Catheter: A Randomised Trial of Hydrochloric Acid Lock Therapy, Mette presents results from a randomised trial exploring an alternative catheter salvage approach. Could hydrochloric acid lock therapy help preserve catheters and challenge current practice?
Xiaohui Chen Nielsen
MD, PhD, is Senior Consultant at the Regional Department of Clinical Microbiology, Zealand University Hospital, Denmark. Her expertise lies in molecular diagnostics and next-generation sequencing (NGS), with research focusing on Streptococcus taxonomy and pathogenesis, as well as microbiome–disease interactions. She has authored more than 60 peer-reviewed publications and book chapters.
Ingvald, Nordøy
MD, PhD. Head of Unit for Clinical Immunology and Infectious Diseases. Specialist in Medical Microbiolgy and Infectious Disease, Oslo University Hospital.
Her research interests include invasive fungal infections and other opportunistic infections.
Ulrikka Nygaard
Is Clinical Professor of Pediatric Infectious Diseases at the University of Copenhagen and consultant at Rigshospitalet. She leads CHILD (CAG Host Infections Laboratory Research Drugs), a nationwide research platform focused on childhood infections. Her research combines randomized controlled trials and omics-based approaches to optimise antibiotic therapy, precision diagnostics, and care for children with infectious diseases.
Else Quist-Paulsen
MD, PhD, works at the Department of Microbiology at Oslo University Hospital, Norway. She is a clinical microbiologist with a primary focus on bacteriology and molecular diagnostics. Her main areas of interest include central nervous system infections, metagenomic next-generation sequencing, and antimicrobial resistance. In recent years, she has contributed to the development of mNGS for clinical use at Oslo University Hospital, to improve the diagnosis of central nervous system infections.
Ole Schmeltz Søgaard
Is an infectious disease physician-scientist at Aarhus University Hospital and Professor at Aarhus University, Denmark.
His research focuses on viral pathogenesis and persistence, with particular emphasis on HIV-1, immune modulation, broadly neutralizing antibodies, and strategies to reverse viral latency. He is dedicated to translating scientific discoveries into improved treatments for people living with HIV.
Simo Sirkeoja
Specialist in internal medicine and infectious diseases, Department of Internal Medicine, Tampere University Hospital, Finland.
He works in clinical practice on an infectious diseases ward and serves as an infection consultant for surgical infections. His main research interest is antibiotic allergies.
Carl Spindler
MD, PhD,
Head of Dpt of Infectious Dis.
Danderyd Hospital, Stockholm, Sweden
Arnfinn Sundsfjord
MD, PhD, is Professor of Medical Microbiology at UiT – The Arctic University of Norway, Senior Consultant at the National Centre for Detection of Antimicrobial Resistance, and Chair of the Norwegian National Antibiotic Committee. His research focuses on host–microbe interactions and antimicrobial resistance, including detection methods, resistance mechanisms, and molecular epidemiology, particularly in enterococci and Gram-negative bacilli.
Ramona Trebbien
DVM, PhD, is Senior Scientist and Head of the Section for Influenza and Respiratory Viruses at Statens Serum Institut, Denmark. She leads the One Health influenza laboratory and has extensive experience in human and animal virology. Her research focuses on zoonotic influenza, viral evolution, and the genetic and antigenic changes driving host adaptation, immune escape, and antiviral resistance.
Jukka Torvikoski
Is a specialist in clinical microbiology at the HUS Diagnostic Centre Bacteriology Laboratory in Helsinki, Finland. His work focuses on blood cultures, bacteriological diagnostics, and antimicrobial stewardship. He recently completed his PhD on the role of bacteriology laboratories in improving antimicrobial use through selective reporting and rapid diagnostic testing.
Christine Årdal
MBA, PhD, has over 25 years of experience in access to medicines across research, public health, government, and healthcare. At the Norwegian Institute of Public Health, her research focuses on antimicrobial access, innovation, and policy. She co-leads the access work package in EU-JAMRAI-2, supporting countries in improving access to critical antibiotics and veterinary vaccines, and previously co-led the DRIVE-AB project on sustainable antibiotic innovation.